PRESS RELEASE published on 07/18/2024 at 07:30, 2 years 3 months ago Nicox Provides Second Quarter 2024 Update Nicox reports €1.6M revenue & €7.8M cash for Q2 2024, extending funds until Feb 2025. Focus on NCX 470 development & Denali trial progress. New Board members appointed Revenue Cash Position Nicox NCX 470 Denali Trial
BRIEF published on 07/16/2024 at 07:35, 2 years 3 months ago Nicox appoints Damian Marron Chairman of the Board of Directors Board Of Directors Ophthalmology Nicox Marc Le Bozec Damian Brown
PRESS RELEASE published on 07/16/2024 at 07:30, 2 years 3 months ago Nicox appoints experienced biotech leader Damian Marron as Chair of the Board and Marc Le Bozec as Director Nicox appoints Damian Marron as Chair of the Board and Marc Le Bozec as Director. Experienced leaders join Nicox Board, Labbe and Kaplan step down. Strategic shift in leadership Board Of Directors Healthcare Nicox Damian Marron Marc Le Bozec
BRIEF published on 06/19/2024 at 07:35, 2 years 4 months ago Nicox succeeds in its capital increase of 3.3 million euros Increase In Capital Ophthalmology Nicox NCX 470 Ocumension Therapeutics
BRIEF published on 06/03/2024 at 07:35, 2 years 5 months ago Nicox SA Announces Voting Rights as of May 31, 2024 Euronext Growth Paris Share Capital Voting Rights AMF Nicox
PRESS RELEASE published on 06/03/2024 at 07:30, 2 years 5 months ago Number of voting rights as of May 31, 2024 Nicox SA monthly publication of the number of shares and voting rights. Details on market, ISIN code, and company's lead programs Voting Rights Shares Ophthalmology Monthly Publication Nicox SA
BRIEF published on 05/31/2024 at 07:35, 2 years 5 months ago Nicox is hosting a webcast for its shareholders on June 6, 2024 Shareholders Webcast Increase In Capital Ophthalmology Nicox
BRIEF published on 05/24/2024 at 07:35, 2 years 5 months ago Nicox: 2024 Ordinary Shareholder Meeting Scheduled for June 28th 2024 Shareholder Meeting Voting Process Ophthalmology Nicox
PRESS RELEASE published on 05/24/2024 at 07:30, 2 years 5 months ago Nicox: 2024 Ordinary Shareholder Meeting to be held on June 28th, 2024 Nicox convenes its 2024 Ordinary Shareholder Meeting on June 28th, 2024, in Sophia Antipolis, France. Shareholders can vote in person, by proxy, or online Shareholder Voting Nicox 2024 Ordinary Shareholder Meeting June 28 2024 Ophthalmology Company
Published on 11/06/2026 at 22:15, 10 hours 38 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 19 hours 53 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 20 hours 23 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 20 hours 23 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 20:15, 12 hours 38 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 13 hours 38 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 13 hours 53 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 14 hours 21 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 14 hours 53 minutes ago ARVERNE GROUP: Number shares and voting rights
Published on 11/06/2026 at 18:00, 14 hours 53 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 14 hours 59 minutes ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 15 hours 18 minutes ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
